2022/3 BCSC 10 Glaucoma

Section 10 provides a comprehensive discussion of glaucoma, including epidemiology and the social and economic impacts of the disease; hereditary and genetic factors; intraocular pressure and aqueous humor dynamics; and clinical evaluation and surgical therapy.

This section includes content on minimally invasive glaucoma surgery (MIGS), coverage of medications such as netarsudil and latanoprostene bunod and analysis of literature on angle closure management. The various classes of medical therapy for glaucoma are described in terms of efficacy, mechanism of action and safety.

Increase your knowledge with the numerous images illustrating disease entities and surgical techniques. Enhanced with eight surgical videos (sample) that will aid your understanding. Both print and eBook users have access to the videos.

Upon completion of Section 10, readers should be able to:

• List recent advances in the understanding of the contribution of genetic factors in glaucoma
• Describe the physiology of aqueous humor dynamics and the control of intraocular pressure (IOP)
• Describe the clinical evaluation of the glaucoma patient, including gonioscopy, optic nerve examination, OCT imaging and perimetry
• List the various clinical features of and therapeutic approaches for the secondary open-angle glaucomas
• Describe the mechanisms, pathophysiology and treatment of angle-closure glaucomas
• Describe how and when to use surgical interventions for glaucoma